Customized anesthetic preservation of ictal threshold in electroconvulsive therapy: Role of adjunctive remifentanil with etomidate

Journal of ECT

Volumn 21, Issue 2, 2005, Pages 128-131

  Augoustides, John G ^a   Hosalkar, Hetal H ^a   O'Reardon, John P ^a   Kofke, W Andrew ^a   Datto, Catherine J ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Electroconvulsive therapy; Etomidate; Pseudocholinesterase deficiency; Remifentanil; Seizure duration

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CHOLINESTERASE; ETOMIDATE; FLUOXETINE; KETOROLAC; LAMOTRIGINE; MIDAZOLAM; NORTRIPTYLINE; OLANZAPINE; ONDANSETRON; OXAZEPAM; PROPOFOL; REMIFENTANIL; SEROTONIN UPTAKE INHIBITOR; SUXAMETHONIUM; TRAZODONE; VENLAFAXINE;

ADULT; ANESTHESIA; ARTICLE; CASE REPORT; DEPRESSION; DRUG DOSE REDUCTION; ELECTROCONVULSIVE THERAPY; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; PARALYSIS; PATIENT SATISFACTION; SEIZURE; TREATMENT OUTCOME; VOMITING;

ADULT; ALCOHOLISM; ANESTHESIA; ANESTHETICS, INTRAVENOUS; ANXIETY DISORDERS; BIPOLAR DISORDER; DIFFERENTIAL THRESHOLD; ELECTROCONVULSIVE THERAPY; ETOMIDATE; HUMANS; MALE; PIPERIDINES;

EID: 20444419811     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yct.0000167463.71704.52     Document Type: Article

References (27)

1. Fried EB. Succinylcholine. In: Atlee J, ed. Complications in Anesthesia. Philadelphia PA; WB Saunders, 1999:77-80.
2. Khan A, Mirolo MH, Hughes D, et al. Electroconvulsive therapy. Psychiatr Clin North Am. 1993;16:497-513.
3. Sullivan PM, Sinz EH, Gunel E, et al. Retrospective comparison of remifentanil vs. methohexital for anesthesia in electroconvulsive therapy. J ECT. 2004;20:219-224.
4. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94:1351-1364.
5. Avramov MN, Husain MM, White PF. The comparative effects of methohexital propofol and etomidate for electroconvulsive therapy. Anesth Analg. 1995;81:596-602.
6. Saffer S, Berk M. Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone. J ECT. 1998;14: 89-93.
7. Trzepacz PT, Weniger FC, Greenhouse J. Etomidate anesthesia increases seizure duration during ECT: a retrospective study. Gen Hosp Psychiatry. 1993;15:115-120.
8. Simpson KH, Halsall PJ, Carr CM, et al. Propofol reduces seizure duration in patients having anesthesia for electroconvulsive therapy. Br J Anaesth. 1988;61:343-344.
9. Rampton AJ, Griffin RM, Stuart CS, et al. A comparison of methohexital and propofol for electroconvulsive therapy: effects on hemodynamic responses and seizure duration. Anesthesiology: 1989;70:412-417.
10. Martensson B, Bartfai A, Hallen B, et al. A comparison between propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry. 1994;35: 179-189.
11. Fredman B, d'Etienne J, Smith I, et al. Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesth Analg. 1994;79:75-79.
12. Martin BA, Cooper RM, Parikh SV. Propofol anesthesia, seizure duration, and ECT: a case report and literature review. J ECT. 1998;14: 99-108.
13. Mokriski BK, Nagle SE, Papuchis GC, et al. Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth. 1992;4:208-212.
14. Potter WZ, Rudorfer MV. Electroconvulsive therapy-a modern medical procedure. N Engl J Med. 1993;328:882-883.
15. Thompson JW, Weiner RD, Myers CP. Use of ECT in the United States in 1975, 1980 and 1986. Am J Psychiatry. 1994;151:1658-1661.
16. American Psychiatric Association Committee on Electroconvulsive Therapy. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging: A Task Force Report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.
17. Ilivicky HJ, Caroff SN, Simone AF. Etomidate during ECT for elderly seizure-resistant patients. Am J Psychiatry. 1995;152:957-958.
18. Swartz CM. A summary of methods to potentiate ECT seizure. Psychiatr Ann. 1996;26:721.
19. McCall WV, Reid S, Rosenquist P, et al. A reappraisal of the role of caffeine in ECT. Am J Psychiatry. 1993;150:1543-1545.
20. Datto C, Rai AK, Ilivicky HJ, et al. Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal. J ECT. 2002;18:118-125.
21. Holas A, Kraftt P, Mauoric M, et al. Remifentanil, propofol or both for conscious sedation during eye surgery under regional anesthesia. Eur J Anesthesiol. 1999;16:741-748.
22. Puchner W, Egger P, Puhringer F, et al. Evaluation of remifentanil as a single drug for awake fibreoptic intubation. Acta Anaesthesiol Scand. 2002;46:350-354.
23. Mastronardi P, Cafiero T, De Cillis P. Remifentanil in anesthesia and intensive care. Minerva Anestesiol. 2000;66:417-423.
24. Anderson FA, Arsland D, Holst-Larsen H. Effects of combined methohexital-remifentanil anesthesia in electro convulsive therapy. Acta Anaesthesiol Scand. 2001;45:830-833.
25. Kramer BA, Afrasiabi A. Atypical cholinesterase and prolonged apnea during electroconvulsive therapy. Convuls Ther. 1991;7:129-132.
26. Risenman JP, Mathew RT. Heterozygous atypical cholinesterase: management during ECT. Convuls Ther. 1992;8:280-284.
27. Hickey DR, O'Connor P, Donati F. Comparison of atracurium and succinylcholine for electroconvulsive therapy in a patient with atypical plasma cholinesterase. Can J Anaesth. 1987;34:280-283.